Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Astex Pharmaceuticals in drug discovery pact with Cancer Research Technology ...domain-BAstex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and Newcastle University have signed a major five-year strategic drug ...See all stories on this topic »Switzerland's Lonza axes 500 jobs to cut costsReuters IndiaThe cuts at the Basel-based firm, which makes pharmaceutical ingredients for drugmakers such as GlaxoSmithKline and Abbott, equate to around 5 percent of its global workforce of about 11,000. In its third-quarter business update on Wednesday, Lonza ...See all stories on this topic »Catalyst Pharmaceutical Partners and BioMarin...

Read more »

Google Alert - pharmaceutical news

News7 new results for pharmaceutical news Fosun Pharmaceutical Shares Fall 8% on Hong Kong DebutWall Street JournalHONG KONG—Drug maker Shanghai Fosun Pharmaceutical (Group) Co., which raised $512 million in the first major initial public offering in Hong Kong in months, saw its shares fall 8% on their debut Tuesday, signaling that demand for new share sales has ...See all stories on this topic »Glenmark Q2 net up nearly three fold at Rs 156.75 crZee NewsNew Delhi: Glenmark Pharmaceuticals on Tuesday said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended September 30, 2012, mainly on account of robust sales across all segments. The company had posted a net ...See all stories on this topic »Zee...

Read more »

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Par Pharmaceutical Acquires Rights to Market and Distribute Generic Seroquel ...Sacramento BeeWOODCLIFF LAKE, N.J., Oct. 29, 2012 -- /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa ...See all stories on this topic »Del Mar Pharmaceuticals Expands Collaboration with Guangxi Wuzhou ...Sacramento BeeVANCOUVER, Oct. 29, 2012 -- /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar") today announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group Co.See all stories on this topic »Shanghai Pharmaceuticals Announces...

Read more »

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Sun Pharmaceutical awaits USFDA approval for cancer drug LipodoxEconomic TimesNEW DELHI: After gaining market access under a contingency plan by the USFDA, drug major Sun Pharmaceutical Industries is awaiting approval from the health regulator for its cancer drug Lipodox. The company's temporary supply of the drug to the US is ...See all stories on this topic »2012's Best Pharmaceutical StockDailyFinanceBig Pharma stocks have rewarded shareholders handsomely in 2012, with shares of many of the top names in the industry up 20% or 30% year to date. While there are plenty of good choices among pharmaceuticals to pick from, perhaps no major player has ...See all stories on this topic »Trial brings...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Pharmaceutical regulatory failure must be remediedLongmont Daily Times-CallWhile investigations are ongoing in the fungal meningitis outbreak that has sickened more than 300 Americans and killed 24, it's clear that the regulatory system that oversees pharmaceutical compounding failed and needs to be strengthened. The steroid ...See all stories on this topic »Pharmaceutical company Boehringer Ingelheim to pay $95 million settlementMilwaukee Journal Sentinel (blog)State and federal governments will be receiving a $95 million boost from a pharmaceutical company accused of improperly marketing four drugs and paying doctors kickbacks as an incentive to prescribe the drugs. The money comes from a settlement...

Read more »

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Pharmaceutical company to pay $95M to settle allegations of improper drug ...Washington PostWASHINGTON — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday. The Justice Department said the ...See all stories on this topic »TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva Receives Approval For ...4-tradersTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved SYNRIBO (omacetaxine mepesuccinate) for Injection to treat adult patients with chronic phase (CP) or accelerated phase (AP) ...See...

Read more »

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Par Pharmaceutical Receives Final Approval To Market Tretinoin CapsulesThe Herald | HeraldOnline.comWOODCLIFF LAKE, N.J., Oct. 25, 2012 — /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval from the U.S. Food and Drug Administration for its ...See all stories on this topic »KV Pharmaceutical, Apple, Huawei: Intellectual PropertyBusinessweekK-V Pharmaceutical Co. (KVPHQ), the drugmaker that blamed lax federal enforcement for its bankruptcy this year, filed a U.S. trade complaint accusing more than 40 compounding pharmacies of infringing its property rights. New England Compounding ...See all...

Read more »